Kumar Ramesh 4
4 · Ocugen, Inc. · Filed Oct 7, 2022
Insider Transaction Report
Form 4
Ocugen, Inc.OCGN
Kumar Ramesh
Director
Transactions
- Sale
Common Stock
2022-10-06$1.83/sh−4,500$8,235→ 0 total - Exercise/Conversion
Option (Right to Buy)
2022-10-06−4,500→ 4,500 totalExercise: $0.51Exp: 2030-01-02→ Common Stock (4,500 underlying) - Exercise/Conversion
Common Stock
2022-10-06$0.51/sh+4,500$2,295→ 4,500 total
Footnotes (2)
- [F1]This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The options, initially representing a right to purchase 54,000 shares, vest and become exercisable in equal monthly installments over three years commencing on February 2, 2020, subject to continued service with Ocugen, Inc. on the applicable vesting dates.